What is the appropriate evaluation and treatment for arm nerve pain?

Arm Nerve Pain: Evaluation and Treatment

For arm nerve pain, begin with a systematic diagnostic approach to confirm neuropathic pain, identify the specific nerve and location involved, then initiate first-line pharmacological treatment with either a secondary-amine tricyclic antidepressant (nortriptyline or desipramine) or gabapentin/pregabalin, while simultaneously addressing the underlying cause through conservative measures or surgical referral if indicated.

Initial Diagnostic Evaluation

The first priority is establishing whether this is truly neuropathic pain versus musculoskeletal pathology. Key distinguishing features to assess:

• Pain quality: Burning, shooting, electric-like pain with paresthesias suggests nerve involvement
• Distribution: Does pain follow a specific nerve territory (median, ulnar, radial, axillary, or cervical nerve root)?
• Provocative activities: Specific positions or repetitive motions that trigger symptoms
• Timing: Acute onset (trauma, fracture) versus insidious (entrapment, compression)

Common diagnostic pitfalls: Lateral elbow pain may be radial tunnel syndrome mimicking lateral epicondylitis; shoulder pain with overhead weakness may be suprascapular nerve injury mimicking rotator cuff tear; forearm pain with pronation may be pronator syndrome rather than carpal tunnel syndrome 1.

Identify the Specific Nerve and Etiology

Based on clinical examination, determine:

• Radial nerve: Most frequently injured major nerve in upper extremity, often from humeral fracture, direct trauma, or compression 2
• Median/ulnar nerve: Entrapment neuropathies in forearm or wrist
• Axillary nerve: Traction injury or blunt shoulder trauma, typically just proximal to quadrilateral space 3
• Brachial plexus: Broader distribution involving multiple nerve territories

Imaging and Electrodiagnostic Studies

Initial evaluation typically does not require imaging 1. However, when symptoms are refractory or diagnosis uncertain:

• Ultrasound: High spatial resolution for real-time nerve characterization, nerve thickening, and muscle atrophy 4
• MR neurography: Superior contrast resolution for nerve signal abnormalities and muscle denervation patterns 5, 4
• Electrodiagnostic testing: Obtain baseline EMG and nerve conduction studies within 4 weeks of injury, with follow-up at 12 weeks 3

Pharmacological Management

Following the established stepwise approach for neuropathic pain 6:

Step 1: Establish Diagnosis and Comorbidities

• Confirm neuropathic pain diagnosis (refer to neurologist if uncertain)
• Identify comorbidities: cardiac disease, renal/hepatic dysfunction, depression, gait instability
• These affect medication selection and dosing

Step 2: Initiate First-Line Treatment

Choose one of the following:

Option A: Secondary-amine TCA (nortriptyline or desipramine)

• Start low dose at bedtime, titrate slowly over 6-8 weeks
• Requires 2 weeks at highest tolerated dose for adequate trial
• Caution: Obtain screening ECG if patient >40 years old; limit to <100 mg/day with cardiac disease or conduction abnormalities
• Anticholinergic effects (dry mouth, orthostatic hypotension, constipation, urinary retention) are common but manageable with slow titration 6

Option B: Calcium channel α2-δ ligand (gabapentin or pregabalin)

• Alternative first-line with different side effect profile
• Better tolerated in elderly or those with cardiac concerns

Option C: SSNRI (duloxetine or venlafaxine)

• Particularly useful if comorbid depression present

For localized peripheral nerve pain: Add topical lidocaine alone or combined with systemic therapy 6

For acute severe pain or cancer-related neuropathic pain: Consider opioids or tramadol for rapid relief during first-line medication titration 6

Step 3: Reassess and Adjust

Frequent reassessment of pain intensity and quality of life:

• Substantial relief (pain ≤3/10): Continue current regimen
• Partial relief (pain ≥4/10) after adequate trial: Add second first-line medication from different class
• Inadequate relief (<30% reduction) at target dose: Switch to alternative first-line medication 6

Step 4: Refractory Cases

If first-line medications fail alone and in combination, refer to pain specialist or multidisciplinary pain center for second/third-line options 6

Conservative Physical Treatment

Neural tissue management provides immediate clinically relevant benefits without harmful effects 7:

• Patient education about nerve-related pain
• Manual therapy techniques
• Nerve gliding exercises
• Advice to continue usual activities as tolerated

This approach (4 treatments over 2 weeks) significantly improves neck pain, arm pain, disability, and function with minimal adverse events 7.

Surgical Considerations

Timing is critical for surgical intervention:

• Majority of patients recover non-operatively 3
• Surgical window: Best results occur when surgery performed within 3-6 months of injury 3
• Indications for surgery: No clinical or electromyographic improvement at 12 weeks, or progressive neurological deficit 3
• Surgical options: Neurolysis, nerve grafting, neurotization, or decompression depending on etiology 2, 3

Prognostic factors favoring recovery:

• Mild injury severity
• Shorter duration of compression
• Ability to cease/decrease aggravating activities 1
• Monofascicular nerve composition (e.g., axillary nerve has better outcomes) 3

Specific surgical scenarios:

• Radial nerve entrapment: Surgical decompression yields good results 2
• Old humeral fracture callus compression: Good neurological recovery with decompression 2
• Direct missile injuries: Worst prognosis 2

Key Clinical Pitfalls to Avoid

1. Don't delay diagnosis: Recovery likelihood decreases with prolonged compression
2. Don't assume musculoskeletal pathology: Always consider nerve injury when pain, weakness, or paresthesias occur without obvious bone/soft tissue injury 1
3. Don't skip cardiac screening with TCAs: ECG mandatory in patients >40 years before initiating tricyclic antidepressants 6
4. Don't abandon treatment prematurely: TCAs require 6-8 weeks for adequate trial 6
5. Don't miss the surgical window: If no improvement by 12 weeks, refer promptly as outcomes decline after 6 months 3